Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00117195 · ClinicalTrials.gov registry record

A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease

A clinical trial, sponsored by Institute for Neurodegenerative Disorders.

Completed
Registry status
620
Enrollment target

NCT00117195 is a clinical trial that has completed, run by Institute for Neurodegenerative Disorders. The registered enrollment target is 620 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00117195 has completed, sponsored by Institute for Neurodegenerative Disorders.

COMPLETED
Registry status
620 participants
Enrollment target

Study Summary

The goal of this study is to investigate neurophysiologic tests that have the potential of serving as screening tools for Parkinson's disease. These neurophysiologic tests will be administered to individuals with Parkinson's disease and parkinsonian syndrome and validated against a healthy control population. Specifically, this study will look at changes in motor function, cognitive function, handwriting, speech, and olfactory function in individuals with Parkinson's disease, individuals at risk for Parkinson's disease and healthy controls.

Interventions

  • DEVICE Automated Neuropsychological Assessment Matrix

Trial Details

FieldValue
Enrollment Target 620 participants
Start Date 2003-05
Est. Completion 2012-01

What the Registry Record Tells You About NCT00117195

The ClinicalTrials.gov registry entry for NCT00117195 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 620 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Institute for Neurodegenerative Disorders, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Automated Neuropsychological Assessment Matrix is the first listed.

NCT00117195 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00117195 about?

NCT00117195 is a clinical study titled "A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease". The goal of this study is to investigate neurophysiologic tests that have the potential of serving as screening tools for Parkinson's disease. These neurophysiologic tests will be administered to individuals with Parkinson's disease and parkinsonian syndrome and validated against a healthy control p...

What is the current status of trial NCT00117195?

This trial is currently completed. The enrollment target is 620 participants. The study started on 2003-05. Estimated completion is 2012-01.

What interventions are being tested in trial NCT00117195?

The interventions under investigation include: Automated Neuropsychological Assessment Matrix (DEVICE).

Who is sponsoring clinical trial NCT00117195?

This trial is sponsored by Institute for Neurodegenerative Disorders, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.